HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jinchen Shao Selected Research
Jinchen Shao Research Topics
Disease
6
Neoplasms (Cancer)
01/2023 - 08/2014
4
Esophageal Squamous Cell Carcinoma
10/2023 - 01/2022
3
Adenocarcinoma
01/2023 - 12/2017
3
Adenocarcinoma of Lung
01/2021 - 04/2015
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 08/2014
2
Lung Neoplasms (Lung Cancer)
01/2015 - 12/2014
1
Neoplasm Metastasis (Metastasis)
09/2023
1
Thymoma (Thymic Carcinoma)
01/2021
1
Neuroendocrine Carcinoma
01/2018
1
Papillomavirus Infections
04/2015
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2015
1
Sarcoma (Soft Tissue Sarcoma)
12/2014
1
Hamartoma
12/2014
1
Chronic Granulomatous Disease
12/2014
1
Malignant Mesothelioma
12/2014
1
Carcinoma (Carcinomatosis)
08/2014
Drug/Important Bio-Agent (IBA)
3
camrelizumab
IBA
09/2023 - 01/2022
3
DNA (Deoxyribonucleic Acid)
IBA
11/2022 - 12/2017
2
Tyrosine Kinase Inhibitors
IBA
11/2022 - 01/2018
2
RNA (Ribonucleic Acid)
IBA
11/2022 - 01/2021
2
Biomarkers (Surrogate Marker)
IBA
01/2021 - 04/2015
2
Proteins (Proteins, Gene)
FDA Link
01/2021 - 08/2014
1
Carboplatin (JM8)
FDA Link
Generic
09/2023
1
130-nm albumin-bound paclitaxel
IBA
09/2023
1
Resistin
IBA
01/2023
1
Folate Receptor 2
IBA
01/2023
1
Member 3 Group A Nuclear Receptor Subfamily 4
IBA
01/2023
1
Ligands
IBA
01/2023
1
Chemokines
IBA
01/2023
1
Anaplastic Lymphoma Kinase
IBA
11/2022
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2021
1
Nonsense Codon (Nonsense Mutation)
IBA
01/2021
1
Vimentin
IBA
11/2018
1
Chromogranins
IBA
01/2018
1
Coloring Agents (Dyes)
IBA
01/2018
1
Synaptophysin
IBA
01/2018
1
Paraffin
IBA
04/2015
1
Virulence Factors (Pathogenicity Factors)
IBA
04/2015
1
Amyloid (Amyloid Fibrils)
IBA
12/2014
1
Matrix Metalloproteinases (MMPs)
IBA
08/2014
1
Caveolin 1
IBA
08/2014
Therapy/Procedure
3
Drug Therapy (Chemotherapy)
09/2023 - 01/2022
2
Esophagectomy
10/2023 - 09/2023
2
Neoadjuvant Therapy
09/2023 - 01/2022
2
Therapeutics
01/2018 - 01/2015
1
Immunotherapy
09/2023
1
Chemoradiotherapy
05/2022
1
Adjuvant Chemotherapy
12/2017